세계의 Pharma 4.0 시장 : 기술별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Pharma 4.0 Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,490,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,424,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,806,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

Pharma 4.0 시장 규모는 2022년에 109억 달러로 평가되어 2023년부터 2030년에 걸쳐 CAGR 17.7%로 확대됩니다.

Pharma 4.0은 실시간 데이터 기반 인사이트, 예측 모델링, 스마트 시스템의 상호 연결성을 활용하여 프로세스를 간소화하고, 제품 품질을 높이며, 민첩한 의사 결정 프로세스를 강화하는 것을 목표로 합니다. 궁극적으로는 환자 중심의 지속 가능한 솔루션을 제공하여 환자 중심의 의료 서비스 시대를 열기 위해 노력합니다. 이를 통해 제약 업계에서 끊임없이 진화하는 도전과 기회를 효과적으로 해결하기 위해 기술 혁신을 수용합니다.

Pharma 4.0 시장 - 시장 역학 :

• 제약 개발을 가속화하고 새로운 치료법을 가져온다는 압력의 고조가 시장 수요를 촉진합니다.
• 제약 산업은 복잡한 질환을 다루고 진화하는 환자의 요구에 신속하게 대응하기 위해 어려움을 겪고 있습니다. Pharma4.0의 등장은 새로운 시대의 도래를 알리고 의약품 개발의 보다 효율적인 경로, 임상시험의 예측 모델링, 생산 공정의 강화를 제공합니다. 이러한 변화는 인공지능, 머신러닝, 데이터 분석 등 첨단 기술의 통합에 달려 있습니다.
• Pharma 4.0은 현저한 시간과 비용 절감을 실현할 뿐만 아니라 새로운 건강 위기, 규제의 변화, 소비자 수요 변화에 대한 대응에 있어서 산업의 적응성을 높입니다. 그 결과 혁신이 가속화되고 획기적인 구명 치료에 대한 접근성이 향상되는 환경이 조성되어 환자에게 새로운 의료 시대가 도래합니다.

Pharma 4.0 시장-세분화 분석 :

• 세계의 Pharma 4.0 시장은 기술, 용도, 최종 사용자 및 지리적 지역을 주요 부문으로 하는 다면적인 세분화 구조를 보여줍니다.
• 기술별 시장은 3가지의 다른 카테고리를 정의하고 있습니다 : 클라우드 컴퓨팅, 인공지능, 빅데이터 분석, 사물인터넷입니다. 주목할 점은 인공지능 부문이 압도적인 우위성을 주장하고 시장 내에서 우세한 세력으로 대두하고 있다는 것입니다.
• Pharma 4.0은 인공지능(AI)의 능력을 활용하여 의약품 부문에 변화의 시대를 가져옵니다. AI를 활용한 알고리즘은 복잡한 데이터 세트 해독, 의약품 연구 가속화, 임상시험 결과 예측 통찰력 제공, 생산 공정 최적화에 도움이 됩니다. AI와 Pharma 4.0의 이 공생 관계는 의사결정 강화, 혁신 증가, 환자 중심 접근법 채택을 특징으로 하는 패러다임 이동을 촉진합니다. 궁극적으로 이러한 시너지 효과는 생산성을 향상시킬 뿐만 아니라 진화하는 헬스케어의 요구에 고도로 대응할 수 있는 헬스케어 에코시스템을 실현합니다.

Pharma 4.0 시장-경쟁 구도 :

Pharma 4.0의 경쟁 환경은 기존 제약 대기업과 혁신적인 스타트업의 융합으로 특징지어지는 역동적인 분야입니다. Pfizer, Novartis, Roche와 같은 업계 강자들이 디지털 혁신을 수용하기 위해 상당한 자원을 투입하고 있는 가운데, AI, 데이터 분석 및 자동화에 전문성을 갖춘 틈새 업체와 기술 스타트업이 파괴적인 솔루션을 도입하며 두각을 나타내고 있습니다.

이러한 환경에서 주목할 만한 트렌드는 제약회사와 기술 제공업체 간의 협력 정신입니다. 이들은 파트너십과 제휴를 구축하여 혁신 문화를 조성하고 있습니다. 급성장하는 Pharma 4.0 시장의 경쟁은 강력한 데이터 플랫폼, 정교한 분석 기능, 민첩한 제조 시스템 구축에 집중되고 있습니다. 이러한 노력은 신약 개발을 가속화하고, 공급망을 최적화하며, 의료 생태계의 진화하는 요구를 충족하는 맞춤형 의료 솔루션을 제공함으로써 경쟁 우위를 확보하는 것을 목표로 합니다.

목차

제1장 Pharma 4.0 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 Pharma 4.0-주요 시장 동향

• 시장 성장 촉진 요인
• 시장 성장 억제 요인
• 시장 기회
• 향후 시장 동향

제4장 Pharma 4.0 산업 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 프레임워크 분석

제5장 Pharma 4.0 시장 : COVID-19 영향 분석

• COVID-19 이전 영향 분석
• COVID-19 이후 영향 분석

제6장 Pharma 4.0 시장 상황

• Pharma 4.0 시장 점유율 분석(2022년)
• 주요 제조사별 분석 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 Pharma 4.0 시장-기술별

• 개요
  • 기술별 부문 점유율 분석
  • 클라우드 컴퓨팅
  • 인공지능
  • 빅데이터 분석
  • 사물인터넷

제8장 Pharma 4.0 시장-용도별

• 개요
  • 용도별 부문 점유율 분석
  • 신약 발견과 개발
  • 임상시험
  • 제조업

제9장 Pharma 4.0 시장-최종 사용자별

• 개요
  • 최종 사용자별 부문 점유율 분석
  • 제약회사
  • 바이오테크놀로지 기업
  • CRO, CMO

제10장 Pharma 4.0 시장-지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조사
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조사
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아 태평양(APAC)
  • 개요
  • 아시아 태평양의 주요 제조사
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 남미
  • 개요
  • 남미의 주요 제조사
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조사
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석-Pharma 4.0 산업

• 경쟁 대시보드
• 기업 개요
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi SA
  • AstraZeneca plc
  • Merck &Co., Inc.
  • Eli Lilly and Company
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited
  • Bristol Myers Squibb Company
  • Moderna, Inc.
  • Regeneron Pharmaceuticals, Inc.

제12장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Pharma 4.0 Market size was valued at USD 10,900 Million in 2022, expanding at a CAGR of 17.7% from 2023 to 2030.

Pharma 4.0 represents the integration of cutting-edge digital technologies, data analytics, robotics, and artificial intelligence into the pharmaceutical industry, aligning with the principles of the fourth industrial revolution. This transformative concept aims to revolutionize various facets of the pharmaceutical sector, encompassing drug research, development, manufacturing, and patient care. Its overarching goals include bolstering operational efficiency, expediting innovation, optimizing supply chain operations, and facilitating the implementation of personalized medicine.

Pharma 4.0 aspires to streamline processes, elevate product quality, and empower agile decision-making processes by harnessing the power of real-time data-driven insights, predictive modeling, and the interconnectivity of smart systems. Ultimately, it strives to usher in an era of healthcare that revolves around the patient, delivering more patient-centric and sustainable solutions. In doing so, it embraces technological innovations to effectively address the ever-evolving challenges and opportunities within the pharmaceutical landscape.

Pharma 4.0 Market - Market Dynamics:

• Increasing pressure to accelerate drug development and bring new therapies to propel market demand

• The pharmaceutical industry grapples with mounting challenges in addressing intricate diseases and meeting evolving patient needs with expediency. The advent of Pharma 4.0 has ushered in a new era, offering more efficient avenues for drug development, predictive modeling for clinical trials, and enhanced production processes. This transformation hinges on the integration of advanced technologies such as artificial intelligence, machine learning, and data analytics.

• Pharma 4.0 not only delivers notable time and cost savings but also enhances the industry's adaptability in responding to emergent health crises, regulatory shifts, and shifting consumer demands. Consequently, it fosters a climate of accelerated innovation and improved accessibility to groundbreaking, life-saving therapies, ushering in a new era of healthcare for patients.

Pharma 4.0 Market - Key Insights:

• According to insights shared by our research analyst, the global Pharma 4.0 market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 18.2% during the forecast period spanning from 2023 to 2030.

• This industry's expansion is underpinned by significant factors, most notably the mounting pressure to expedite drug development processes and introduce novel therapies to market.

• Within the context of Technology segmentation, Artificial Intelligence emerges as the standout category, capturing the majority of the market share for the year 2022.

• Furthermore, in the realm of application segmentation, Clinical Trials takes the lead in 2022, underscoring the pivotal role of Pharma 4.0 in optimizing and expediting clinical research processes.

• From a regional perspective, North America emerges as the primary revenue contributor in the year 2022, reflecting the region's commitment to embracing Pharma 4.0 as a means to drive innovation and enhance healthcare outcomes.

Pharma 4.0 Market- Segmentation Analysis:

• The Global Pharma 4.0 Market exhibits a multifaceted segmentation structure, comprising Technology, Application, End-User, and Geographical Region as its primary divisions.

• Under the umbrella of Technology classification, the market delineates three distinct categories: Cloud Computing, Artificial Intelligence, Big Data Analytics, and the Internet of Things. Remarkably, it is the Artificial Intelligence sector that asserts its dominance, emerging as the predominant force within the market.

• Pharma 4.0 harnesses the capabilities of artificial intelligence (AI) to usher in a transformative era for the pharmaceutical sector. AI-powered algorithms are instrumental in deciphering complex datasets, expediting drug research, offering predictive insights into clinical trial outcomes, and optimizing production processes. This symbiotic relationship between AI and Pharma 4.0 fosters a paradigm shift characterized by enhanced decision-making, heightened innovation, and the adoption of patient-centric approaches. Ultimately, this synergy results in a healthcare ecosystem that is not only more productive but also highly responsive to evolving healthcare needs.

Pharma 4.0 Market- Competitive Landscape:

Pharma 4.0's competitive landscape is a dynamic arena characterized by the convergence of established pharmaceutical giants and innovative startups. While industry stalwarts like Pfizer, Novartis, and Roche commit substantial resources to embrace the digital transformation, a wave of niche players and technology startups with expertise in AI, data analytics, and automation are making their mark by introducing disruptive solutions.

In this landscape, a noteworthy trend is the collaborative spirit between pharmaceutical firms and technology providers. They are forging partnerships and alliances, fostering a culture of innovation. The competition in the burgeoning Pharma 4.0 market is centered on the establishment of robust data platforms, sophisticated analytics capabilities, and agile manufacturing systems. These endeavors aim to confer a competitive edge by accelerating drug discovery, optimizing supply chains, and delivering personalized healthcare solutions to meet the evolving needs of the healthcare ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMA 4.0 MARKET KEY PLAYERS

• Pfizer Inc.
• Roche Holding AG
• Novartis AG
• Johnson & Johnson
• GlaxoSmithKline plc
• Sanofi S.A.
• AstraZeneca plc
• Merck & Co., Inc.
• Eli Lilly and Company
• AbbVie Inc.
• Boehringer Ingelheim International GmbH
• Takeda Pharmaceutical Company Limited
• Bristol Myers Squibb Company
• Moderna, Inc.
• Regeneron Pharmaceuticals, Inc.

GLOBAL PHARMA 4.0 MARKET, BY TECHNOLOGY

• Cloud Computing
• Artificial Intelligence
• Big Data Analytics
• Internet of Things

GLOBAL PHARMA 4.0 MARKET, BY APPLICATION

• Drug Discovery and Development
• Clinical Trials
• Manufacturing

GLOBAL PHARMA 4.0 MARKET, BY END-USER

• Pharmaceutical Companies
• Biotechnology Companies
• CROs and CMOs

GLOBAL PHARMA 4.0 MARKET, BY REGION

• North America
• The U.S.
• Canada

• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe

• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC

• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Pharma 4.0 Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Pharma 4.0 Market Snippet by Technology
  • 2.1.2. Pharma 4.0 Market Snippet by Application
  • 2.1.3. Pharma 4.0 Market Snippet by End-User
  • 2.1.4. Pharma 4.0 Market Snippet by Country
  • 2.1.5. Pharma 4.0 Market Snippet by Region
• 2.2. Competitive Insights

3. Pharma 4.0 Key Market Trends

• 3.1. Pharma 4.0 Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Pharma 4.0 Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Pharma 4.0 Market Opportunities
• 3.4. Pharma 4.0 Market Future Trends

4. Pharma 4.0 Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Pharma 4.0 Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Pharma 4.0 Market Landscape

• 6.1. Pharma 4.0 Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Pharma 4.0 Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
  • 7.1.2. Cloud Computing
  • 7.1.3. Artificial Intelligence
  • 7.1.4. Big Data Analytics
  • 7.1.5. Internet of Things

8. Pharma 4.0 Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. Drug Discovery and Development
  • 8.1.3. Clinical Trials
  • 8.1.4. Manufacturing

9. Pharma 4.0 Market - By End-User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
  • 9.1.2. Pharmaceutical Companies
  • 9.1.3. Biotechnology Companies
  • 9.1.4. CROs and CMOs

10. Pharma 4.0 Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Pharma 4.0 Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Pharma 4.0 Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Pharma 4.0 Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Pharma 4.0 Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Pharma 4.0 Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pharma 4.0 Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Pfizer Inc.
  • 11.2.2. Roche Holding AG
  • 11.2.3. Novartis AG
  • 11.2.4. Johnson & Johnson
  • 11.2.5. GlaxoSmithKline plc
  • 11.2.6. Sanofi S.A.
  • 11.2.7. AstraZeneca plc
  • 11.2.8. Merck & Co., Inc.
  • 11.2.9. Eli Lilly and Company
  • 11.2.10. AbbVie Inc.
  • 11.2.11. Boehringer Ingelheim International GmbH
  • 11.2.12. Takeda Pharmaceutical Company Limited
  • 11.2.13. Bristol Myers Squibb Company
  • 11.2.14. Moderna, Inc.
  • 11.2.15. Regeneron Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료